Resmed Inc (NASDAQ:RMD) over-valued by 10%
| Website | https://www.resmed.com/ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Fiscal Year End | Jun 30, 2021 |
| Market Cap | $28,210,118,656 |
| Beta | 0.318257 |
| Average Volume | $632,029 |
| Last Dividend | 1.56% |
| Price on Jan 28, 2022 | $246.75 |
| Autochartist™ Valuation | $221.45 |
| Conclusion |
10% over-valued |
| Download Report |
